Drug Trial Radar · NCT01659580
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
Last checked: Nov 19, 2026Latest source record: Mar 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,004
Actual
Start
Aug 2012
Primary completion
Dec 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- Tasly Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 8, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III study is designed as a double blind, randomized, multi-nation, multi-center, placebo controlled clinical research, which aims to evaluate the safety and efficacy of Dantonic® (T89) in patients with chronic stable angina pectoris.
Conditions
- Angina Pectoris
Interventions
T89 high doseDrug
225mg bid
T89 Low doseDrug
150mg bid
Sanqi+BingpianDrug
225 mg bid
PlaceboDrug
225mg bid
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change of symptom-limited TED from baseline compared to placebo at the end of week 4.Time frame: 4 weeks
Locations
94 sites in 7 countries. Site status is shown where the registry gives one.
Cardiology and Medicine Clinic
Little Rock, Arkansas
Beaver Medical Clinic
Banning, California
Foundation for Cardiovascular Medicine
La Jolla, California
Precision Research Institute
National City, California
Paradigm Clinical Research Institute, Inc.
Torrance, California
Harbor-UCLA Medical Center
Torrance, California
Jacksonville Center for Clinical Research
Jacksonville, Florida
Brevard Cardiovascular Research Associates
Merritt, Florida
SouthCoast Research Center, Inc
Miami, Florida
Molecular Imaging Research and Clinical Trials
Miami, Florida
Integrity Clinical Trials
Miami, Florida
NewPhase Clinical Trials, Inc.
Miami Beach, Florida
Peninsula Research, Inc.
Ormond Beach, Florida
Cardiovascular Center of Sarasota
Sarasota, Florida
Jedidiah Clinical Research
Tampa, Florida
Athens Heart Center
Athens, Georgia
Atlanta Clinical Research Center
Atlanta, Georgia
Ellipsis Research
Atlanta, Georgia
Central Cardiology
Campbellsville, Kentucky
Alexandria Cardiology Clinic
Alexandria, Louisiana
Tulane University Health Science Center, Tulane University Heart & Vascular Institute
New Orleans, Louisiana
Manhattan Medical Research Practice
New York, New York
Cleveland Clinic
Medina, Ohio
Hillsboro Cardiology, PC
Hillsboro, Oregon
Kore CV Research
Jackson, Tennessee
Tennessee Center for Clinical Trials
Tullahoma, Tennessee
Angiocardiac Care of Texas, PA
Houston, Texas
Northwest Houston Cardiology
Houston, Texas
Cardiology Center of Houston, PA
Katy, Texas
Northwest Heart Center
Tomball, Texas
Minsk Regional Clinical Hospital
Minsk, Belarus, Belarus
Dr. Petr Polasek, MD, Office of
Kelowna, British Columbia, Canada
The Medical Arts Health Research Group
North Vancouver, British Columbia, Canada
Victoria Heart Institute Foundation
Victoria, British Columbia, Canada
Dixie Medical Group
Mississauga, Ontario, Canada
Bakbak Medicine Professional Corporation
Oshawa, Ontario, Canada
Heart Care Research
Oshawa, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
ViaCar Recherche Clinique Inc.
Brossard, Quebec, Canada
ViaCar Recherche Clinique Inc.
Greenfield Park, Quebec, Canada
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.